Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
After finishing at $5.97 in the prior trading day, Mind Medicine Inc (NASDAQ: MNMD) closed at $5.87, down -1.68%. In other words, the price has decreased by -$1.68 from its previous closing price. On the day, 0.85 million shares were traded. MNMD stock price reached its highest trading level at $5.99 during the session, while it also had its lowest trading level at $5.83.
Ratios:
Our goal is to gain a better understanding of MNMD by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 5.92 and its Current Ratio is at 5.92. In the meantime, Its Debt-to-Equity ratio is 0.12 whereas as Long-Term Debt/Eq ratio is at 0.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for this company, ROTH MKM on July 24, 2024, initiated with a Buy rating and assigned the stock a target price of $36.
On May 29, 2024, Robert W. Baird started tracking the stock assigning a Outperform rating and target price of $27.
On April 15, 2024, Leerink Partners started tracking the stock assigning a Outperform rating and target price of $20.Leerink Partners initiated its Outperform rating on April 15, 2024, with a $20 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Aug 23 ’24 when GRYSKA DAVID W bought 3,500 shares for $5.98 per share. The transaction valued at 20,930 led to the insider holds 17,351 shares of the business.
Barrow Robert bought 500 shares of MNMD for $3,155 on Aug 19 ’24. The Chief Executive Officer now owns 565,043 shares after completing the transaction at $6.31 per share. On Aug 20 ’24, another insider, Barrow Robert, who serves as the Chief Executive Officer of the company, bought 500 shares for $6.12 each. As a result, the insider paid 3,060 and bolstered with 565,543 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MNMD now has a Market Capitalization of 477996992 and an Enterprise Value of 204609968.
Stock Price History:
Over the past 52 weeks, MNMD has reached a high of $12.22, while it has fallen to a 52-week low of $2.41. The 50-Day Moving Average of the stock is -16.86%, while the 200-Day Moving Average is calculated to be -14.38%.
Shares Statistics:
The stock has traded on average 1.16M shares per day over the past 3-months and 817680 shares per day over the last 10 days, according to various share statistics. A total of 41.10M shares are outstanding, with a floating share count of 27.27M. Insiders hold about 3.19% of the company’s shares, while institutions hold 144.16% stake in the company. Shares short for MNMD as of 1724976000 were 9905914 with a Short Ratio of 8.51, compared to 1722384000 on 9977666. Therefore, it implies a Short% of Shares Outstanding of 9905914 and a Short% of Float of 12.1800005.
